Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [699]
News [2441]
Articles [197]
Editorials [6]
Conferences [89]
elearning [31]
Perifosine disappoints in refractory mCRC
Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA
Perifosine disappoints in refractory mCRC ( Dr Johanna Bendell – Sarah Cannon Research Institute, Nashville, USA )
16 Jul 2012
Screening and specialist nurses central to patient care
Jola Gore-Booth – EuropaColon, France / UK
Screening and specialist nurses central to patient care ( Jola Gore-Booth – EuropaColon, France / UK )
16 Jul 2012
Tivantinib first drug to have overall survival benefit as second-line...
Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia...
Tivantinib first drug to have overall survival benefit as second-line hepatocellular carcinoma treatment ( Dr Camillo Porta – Fondazione IRCCS Policlinico Universitario San Matteo, Pavia, Italy )
16 Jul 2012
Adjuvant cetuximab disappoints again in mCRC
Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France
Adjuvant cetuximab disappoints again in mCRC ( Prof Michel Ducreux – Institut Gustave Roussy, Villejuif, France )
16 Jul 2012
Young Voices United against CRC
Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia
Young Voices United against CRC ( Dr Dino Tarabar – Military Medical Academy, Belgrade, Serbia )
16 Jul 2012
Advances in radiotherapy for rectal cancer
Dr Karin Haustermans – University Hospital Leuven, Belgium
Advances in radiotherapy for rectal cancer ( Dr Karin Haustermans – University Hospital Leuven, Belgium )
16 Jul 2012
Important to support young medical oncologists’ research
Prof Roberto Labianca – Riuniti Hospital, Bergamo, Italy
Important to support young medical oncologists’ research ( Prof Roberto Labianca – Riuniti Hospital, Bergamo, Italy )
16 Jul 2012
Role of family history and genetic testing in diagnosis
Dr Marie Wood – University of Vermont, Burlington, USA
Role of family history and genetic testing in diagnosis ( Dr Marie Wood – University of Vermont, Burlington, USA )
15 Jun 2012
Effects of panitumumab against oesophageal-gastro cancer and carcinomas
Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK
Effects of panitumumab against oesophageal-gastro cancer and carcinomas ( Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK )
15 Jun 2012
Regorafenib effective for GISTs that progress due to resistance to approved...
Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA
Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA )
13 Jun 2012
President's overview of ASCO 2012
Dr Michael Link - Stanford School of Medicine, California, USA
President's overview of ASCO 2012 ( Dr Michael Link - Stanford School of Medicine, California, USA )
4 Jun 2012
Regorafenib effective for GISTs that progress due to resistance to approved...
Dr George Demetri - Dana Farber Cancer Institute, Boston, USA
Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George Demetri - Dana Farber Cancer Institute, Boston, USA )
4 Jun 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation